[Federal Register Volume 78, Number 152 (Wednesday, August 7, 2013)]
[Rules and Regulations]
[Pages 48051-48068]
[FR Doc No: 2013-18982]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 9 and 721

[EPA-HQ-OPPT-2013-0399; FRL-9393-4]
RIN 2070-AB27

Significant New Use Rules on Certain Chemical Substances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Direct final rule.

-----------------------------------------------------------------------

SUMMARY: EPA is promulgating significant new use rules (SNURs) under
the Toxic Substances Control Act (TSCA) for 53 chemical substances
which were the subject of premanufacture notices (PMNs). Seven of these
chemical substances are subject to TSCA section 5(e) consent orders
issued by EPA. This action requires persons who intend to manufacture
or process any of these 53 chemical substances for an activity that is
designated as a significant new use by this rule to notify EPA at least
90 days before commencing that activity. The required notification will
provide EPA with the opportunity to evaluate the intended use and, if
necessary, to prohibit or limit that activity before it occurs.

DATES: This rule is effective on October 7, 2013. For purposes of
judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on
August 21, 2013.
    Written adverse or critical comments, or notice of intent to submit
adverse or critical comments, on one or more of these SNURs must be
received on or before September 6, 2013 (see Unit VI. of the
SUPPLEMENTARY INFORMATION). If EPA receives written adverse or critical
comments, or notice of intent to submit adverse or critical comments,
on one or more of these SNURs before September 6, 2013, EPA will
withdraw the relevant sections of this direct final rule before its
effective date.
    For additional information on related reporting requirement dates,
see Units I.A., VI., and VII. of the SUPPLEMENTARY INFORMATION.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2013-0399, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments.
     Mail: Document Control Office (7407M), Office of Pollution
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington, DC 20460-0001.
     Hand Delivery: OPPT Document Control Office (DCO), EPA
East Bldg., Rm. 6428, 1201 Constitution Ave. NW., Washington, DC. ATTN:
Docket ID Number EPA-HQ-OPPT-2013-0399. The DCO is open from 8 a.m. to
4 p.m., Monday through Friday, excluding legal holidays. The telephone
number for the DCO is<PHONE_NUMBER>. Such deliveries are only accepted
during the DCO's normal hours of operation, and special arrangements
should be made for deliveries of boxed information.
    Instructions: Direct your comments to docket ID number EPA-HQ-OPPT-
2013-0399. EPA's policy is that all comments received will be included
in the docket without change and may be made available at http://www.regulations.gov, including any personal information provided,
unless the comment includes information claimed to be Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. Do not submit information that you consider to
be CBI or otherwise protected through regulations.gov or email. The
regulations.gov Web site is an ``anonymous access'' system, which means
EPA will not know your identity or contact information unless you
provide it in the body of your comment. If you send an email comment
directly to EPA without going through regulations.gov, your email
address will be automatically captured and included as part of the
comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
    Docket: All documents in the docket are listed in the docket index
available at http://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, will be publicly available only
in hard copy. Publicly available docket materials are available
electronically at http://www.regulations.gov, or, if only available in
hard copy, at the OPPT Docket. The OPPT Docket is located in the EPA
Docket Center (EPA/DC) at Rm. 3334, EPA West Bldg., 1301 Constitution
Ave. NW., Washington, DC. The EPA/DC Public Reading Room hours of
operation are 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding
legal holidays. The telephone number of the EPA/DC Public Reading Room
is<PHONE_NUMBER>, and the telephone number for the OPPT Docket is
(202) 566-0280. Docket visitors are required to show photographic
identification, pass through a metal detector, and sign the EPA visitor
log. All visitor bags are processed through an X-ray machine and
subject to search. Visitors will be provided an EPA/DC badge that must
be visible at all times in the building and returned upon departure.

FOR FURTHER INFORMATION CONTACT: For technical information contact:
Kenneth Moss, Chemical Control Division (7405M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington, DC 20460-0001; telephone number:
(202) 564-9232; email address<EMAIL_ADDRESS>    For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you manufacture,
process, or use the chemical substances contained in this rule. The
following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Manufacturers or processors of one or more subject
chemical substances (NAICS codes 325 and 324110), e.g., chemical
manufacturing and petroleum refineries. This action may also affect
certain entities through pre-existing import certification and export
notification rules under TSCA. Chemical importers are subject to the
TSCA section 13 (15 U.S.C. 2612) import certification requirements
promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical
importers must certify that the shipment of the chemical substance
complies with all applicable rules and orders under TSCA. Importers of
chemicals subject to these SNURs must certify their compliance with the
SNUR requirements. The EPA policy in support of import certification
appears at 40 CFR part 707, subpart B. In addition, any persons who
export or intend to export a chemical substance that is the subject of
a proposed or final SNUR, are subject to the export notification
provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see Sec.
721.20), and must comply with the export notification requirements in
40 CFR part 707, subpart D.

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.

    2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period
deadline identified.

II. Background

A. What action is the agency taking?

    EPA is promulgating these SNURs using direct final procedures.
These SNURs will require persons to notify EPA at least 90 days before
commencing the manufacture or processing of a chemical substance for
any activity designated by these SNURs as a significant new use.
Receipt of such notices allows EPA to assess risks that may be
presented by the intended uses and, if appropriate, to regulate the
proposed use before it occurs. Additional rationale and background to
these rules are more fully set out in the preamble to EPA's first
direct final SNUR published in the Federal Register issue of April 24,
1990 (55 FR 17376). Consult that preamble for further information on
the objectives, rationale, and procedures for SNURs and on the basis
for significant new use designations, including provisions for
developing test data.

B. What is the agency's authority for taking this action?

    Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to
determine that a use of a chemical substance is a ``significant new
use.'' EPA must make this determination by rule after considering all
relevant factors, including the four bulleted TSCA section 5(a)(2)
factors listed in Unit III. Once EPA determines that a use of a
chemical substance is a significant new use, TSCA section 5(a)(1)(B)
requires persons to submit a significant new use notice (SNUN) to EPA
at least 90 days before they manufacture or process the chemical
substance for that use. Persons who must report are described in Sec.
14;721.5.

C. Applicability of General Provisions

    General provisions for SNURs appear in 40 CFR part 721, subpart A.
These provisions describe persons subject to the rule, recordkeeping
requirements, exemptions to reporting requirements, and applicability
of the rule to uses occurring before the effective date of the rule.
Provisions relating to user fees appear at 40 CFR part 700. According
to Sec.  14;721.1(c), persons subject to these SNURs must comply with
the same SNUN requirements and EPA regulatory procedures as submitters
of PMNs under TSCA section 5(a)(1)(A). In particular, these
requirements include the information submission requirements of TSCA
section 5(b) and 5(d)(1), the exemptions authorized by TSCA section
5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part
720. Once EPA receives a SNUN, EPA may take regulatory action under
TSCA section 5(e), 5(f), 6, or 7 to control the activities for which it
has received the SNUN. If EPA does not take action, EPA is required
under TSCA section 5(g) to explain in the Federal Register its reasons
for not taking action.

III. Significant New Use Determination

    Section 5(a)(2) of TSCA states that EPA's determination that a use
of a chemical substance is a significant new use must be made after
consideration of all relevant factors, including:
     The projected volume of manufacturing and processing of a
chemical substance.
     The extent to which a use changes the type or form of
exposure of human beings or the environment to a chemical substance.
     The extent to which a use increases the magnitude and
duration of exposure of human beings or the environment to a chemical
substance.
     The reasonably anticipated manner and methods of
manufacturing, processing, distribution in commerce, and disposal of a
chemical substance.
    In addition to these factors enumerated in TSCA section 5(a)(2),
the statute authorized EPA to consider any other relevant factors.
    To determine what would constitute a significant new use for the 53
chemical substances that are the subject of these SNURs, EPA considered
relevant information about the toxicity of the chemical substances,
likely human exposures and environmental releases associated with
possible uses, and the four bulleted TSCA section 5(a)(2) factors
listed in this unit.

IV. Substances Subject to This Rule

    EPA is establishing significant new use and recordkeeping
requirements for 53 chemical substances in 40 CFR part 721, subpart E.
In this unit, EPA provides the following information for each chemical
substance:
     PMN number.
     Chemical name (generic name, if the specific name is
claimed as CBI).
     Chemical Abstracts Service (CAS) Registry number (if
assigned for non-confidential chemical identities).
     Basis for the TSCA section 5(e) consent order or, for TSCA
non-section 5(e) SNURs, the basis for the SNUR (i.e., SNURs without
TSCA section 5(e) consent orders).
     Tests recommended by EPA to provide sufficient information
to evaluate the chemical substance (see Unit VIII. for more
information).
     CFR citation assigned in the regulatory text section of
this rule.
    This rule includes PMN substances, P-09-198 and P-09-199, whose
reported chemical names include the term ``carbon nanotube'' or
``CNT''. Because of a lack of established nomenclature for carbon
nanotubes, the TSCA Inventory names for carbon nanotubes are currently
in generic form, e.g., carbon nanotube (CNT), multi-walled carbon
nanotube (MWCNT), double-walled carbon nanotube (DWCNT), or single-
walled carbon nanotube (SWCNT). EPA uses the specific structural
characteristics provided by the PMN submitter to more specifically
characterize the Inventory listing for an individual CNT. All
submitters of new chemical notices for CNTs in this SNUR have claimed
those specific structural characteristics as CBI. EPA is publishing the
generic chemical name along with the PMN number to identify that a
distinct chemical substance was the subject of the PMN without
revealing the confidential chemical identity of the PMN substance.
Confidentiality claims preclude a more detailed description of the
identity of these CNTs. If an intended manufacturer or processor of
CNTs is unsure of whether its CNTs are subject to this SNUR or any
other SNUR, the company can either contact EPA or obtain a written
determination from EPA pursuant to the bona fide procedures at Sec.
721.11. EPA is using the specific structural characteristics, for all
CNTs submitted as new chemical substances

under TSCA, to help develop standard nomenclature for placing these
chemical substances on the TSCA Inventory. EPA has compiled a generic
list of those structural characteristics entitled ``Material
Characterization of Carbon Nanotubes for Molecular Identity (MI)
Determination & Nomenclature.'' A copy of this list is available in the
docket for these SNURs under docket ID number EPA-HQ-OPPT-2013-0399. If
EPA develops a more specific generic chemical name for these materials,
that name will be made publicly available.
    The regulatory text section of this rule specifies the activities
designated as significant new uses. Certain new uses, including
production volume limits (i.e., limits on manufacture volume) and other
uses designated in this rule may be claimed as CBI. Unit IX. discusses
a procedure companies may use to ascertain whether a proposed use
constitutes a significant new use.
    This rule includes 7 PMN substances (P-09-198, P-09-199, P-09-447,
P-09-448, P-12-539, P-13-107, and P-13-109) that are subject to ``risk-
based'' consent orders under TSCA section 5(e)(1)(A)(ii)(I) where EPA
determined that activities associated with the PMN substances may
present unreasonable risk to human health or the environment. Those
consent orders require protective measures to limit exposures or
otherwise mitigate the potential unreasonable risk. The so-called
``5(e) SNURs'' on these PMN substances are promulgated pursuant to
Sec.  721.160 and are based on and consistent with the provisions in
the underlying consent orders. The 5(e) SNURs designate as a
``significant new use'' the absence of the protective measures required
in the corresponding consent orders.
    In addition, this rule includes SNURs on 3 PMN substances (P-12-
539, P-13-107, and P-13-109) that are subject to ``exposure-based''
consent orders under TSCA section 5(e)(1)(A)(ii)(II), wherein EPA
determined that the PMN substances are expected to be produced in
substantial quantities, and that there may either be significant or
substantial human exposure and/or the PMN substance may enter the
environment in substantial quantities. The TSCA section 5(e) consent
orders require submission of certain test data to EPA before the
manufacturer may exceed a specified production volume. These SNURs
designate as a ``significant new use'' the absence of the protective
measures or exceedance of the production volume limit required in the
TSCA section 5(e) consent orders.
    This rule also includes SNURs on 46 PMN substances that are not
subject to consent orders under TSCA section 5(e). In these cases, for
a variety of reasons, EPA did not find that the use scenario described
in the PMN triggered the determinations set forth under TSCA section
5(e). However, EPA does believe that certain changes from the use
scenario described in the PMN could result in increased exposures,
thereby constituting a ``significant new use.'' These so-called ``non-
section 5(e) SNURs'' are promulgated pursuant to Sec.  721.170. EPA has
determined that every activity designated as a ``significant new use''
in all non-section 5(e) SNURs issued under Sec.  721.170 satisfies the
two requirements stipulated in Sec.  721.170(c)(2), i.e., these
significant new use activities, ``(i) are different from those
described in the premanufacture notice for the substance, including any
amendments, deletions, and additions of activities to the
premanufacture notice, and (ii) may be accompanied by changes in
exposure or release levels that are significant in relation to the
health or environmental concerns identified'' for the PMN substance.

PMN Numbers P-09-198 and P-09-199

    Chemical names: Multi-walled carbon nanotubes (generic).
    CAS numbers: Not available.
    Effective date of TSCA section 5(e) consent order: June 4, 2010.
    Basis for TSCA section 5(e) consent order: The consolidated PMN
states that the generic (non-confidential) use of the substances will
be as additives for reinforcement. Based on test data on analogous
respirable, poorly soluble particulates and other CNTs, EPA identified
concerns for pulmonary toxicity, fibrosis, carcinogenicity,
mutagenicity, and immunotoxicity. Further, available data suggests that
pulmonary deposition of some nanoparticles, including CNT may induce
cardiovascular toxicity if inhaled. The order was issued under section
5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA based on a finding that
these substances may present an unreasonable risk of injury to human
health. To protect against this risk, the consent order requires:
    1. Use of personal protective equipment including gloves and
protective clothing impervious to the substances when there is
potential dermal exposure and a National Institute of Occupational
Safety and Health (NIOSH)-certified full-face respirator with N-100
cartridges when there is potential inhalation exposure.
    2. No domestic manufacture.
    3. Use of the substances only as described in the consent order.
    4. No use of the substances resulting in surface water releases
during processing and use.
    Recommended testing: EPA has determined that the following tests
would help characterize possible effects of the PMN substances. The PMN
submitter has agreed not to exceed a specified production/time limit
without performing a 90-day inhalation toxicity test (OPPTS Test
Guideline 870.3465) in rats with a post exposure observation period of
up to 3 months, bronchoalveolar lavage fluid (BALF) analysis, a
determination of cardiovascular toxicity (clinically-based blood/plasma
protein analyses), histopathology of the heart, and certain physical/
chemical data.
    CFR citation: 40 CFR 721.10671.

PMN Numbers P-09-447 and P-09-448

    Chemical name: Sodium olefin sulfonate derivative (generic).
    CAS number: Not available.
    Effective date of TSCA section 5(e) consent order: February 15,
2013.
    Basis for TSCA section 5(e) consent order: The PMNs state that the
generic (non-confidential) use of the substances will be enhanced oil
recovery applications. Based on a CBI analog, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 10 parts per
billion (ppb) of the aggregate of these PMN substances in surface
waters. The consent order was issued under TSCA sections 5(e)(1)(A)(i)
and 5(e)(1)(A)(ii)(I) based on a finding that uncontrolled manufacture,
processing, distribution in commerce, use, and disposal of these
substances may present an unreasonable risk of injury to the
environment. To protect against these risks, the consent order
requires:
    1. Establishment and use of a hazard communication program.
    2. Use of the substances only as described in the consent order.
    3. No use of the substances resulting in surface water
concentrations exceeding 10 ppb of the aggregate of these PMN
substances.
    Recommended testing: EPA has determined that a daphnid chronic
toxicity test (OPPTS Test Guidelines 850.1300) and a fish early life
stage toxicity test (OPPTS Test Guidelines 850.1400) on either P-09-447
or P-09-448, would help characterize the environmental effects of the
PMN substances. The order does not require the submission of these
tests at any specified time or production volume. However, the order's
restrictions on manufacture, processing, distribution in commerce, use,
and disposal of the PMN substances will remain in effect

until the order is modified or revoked by EPA based on submission of
that or other relevant information.
    CFR citation: 40 CFR 721.10672.

PMN Numbers P-12-539, P-13-107, and P-13-109

    Chemical names: Alkanes, C21-34--branched and linear, chloro (P-12-
539), Alkanes, C22-30--branched and linear, chloro (P-13-107); and
Alkanes, C24-28, chloro (P-13-109).
    CAS numbers: 1417900-96-9 (P-12-539), 1401947-24-0 (P-13-107), and
1402738-52-6 (P-13-109).
    Effective date of TSCA section 5(e) consent order: March 19, 2013.
    Basis for TSCA section 5(e) consent order: The PMNs state that the
uses of the substances are as flame retardants/plasticizers in polymers
and extreme pressure lubricants in metal working fluids (MWFs). There
are also several CBI uses that are generically described as:
Plasticizer and lubricant with flame retardant properties. By analogy
to medium chain chlorinated paraffins (MCCPs--alkyl chain length of 14
to 17), EPA expects very long chain chlorinated paraffins (vLCCPs) and
possible degradation products to be potentially highly persistent,
potentially bioaccumulative, and potentially toxic. Transport and
magnification across trophic levels may also result in toxicity to
higher organisms, including fish, higher predators, and potentially
humans. EPA has concerns about the potential for the vLCCPs to degrade
to shorter chain chlorinated compounds, as well as concerns about
potential impurities or small fractions of MCCPs and/or long-chain
chlorinated paraffins (LCCPs--alkyl chain length of 18 to 20). The
consent order was issued under TSCA sections 5(e)(1)(A)(i),
5(e)(1)(A)(ii)(I), and 5(e)(1)(A)(ii)(II) based on a finding that these
substances may present an unreasonable risk of injury to the
environment and the substances may be produced in substantial
quantities and may reasonably be anticipated to enter the environment
in substantial quantities, and there may be significant (or
substantial) human exposures to the PMN substances. To protect against
these risks, the consent order requires:
    1. Manufacture or import of the substances at a cumulative,
aggregate volume not to exceed 1,200,000 kilograms (kg), 14,100,000 kg,
59,100,000 kg, 78,400,000 kg, and 86,100,000 kg unless the company has
submitted the results of certain environmental effects studies.
    2. No manufacture of the substances with the amount of chlorinated
paraffins with an alkyl chain <= 20 to exceed more than 1% of that PMN
substance by weight.
    Recommended testing: EPA has determined that analysis for chain
length and percent chlorination (for example by gas chromatography-mass
spectrometry or high performance liquid chromatography-mass
spectrometry (GC/MS HPLC/MS)); a modified semi-continuous activated
sludge (SCAS) test (OPPTS Test Guideline 835.3210), modified SCAS test
for insoluble and volatile chemicals (OPPTS Test Guideline 835.5045),
or Zahn Wellens/EMPA test (OPPTS Test Guideline 835.3200); aerobic and
anaerobic soil metabolism studies (Organisation for Economic Co-
operation and Development (OECD) Test Guideline 307); a bioaccumulation
in sediment-dwelling benthic oligochaetes test (OECD Test Guideline
315) on the PMN substances and their potential degradation products;
and a sediment-water chironomid life-cycle toxicity test using spiked
water or spiked sediment test (OECD Test Guideline 233) or a sediment-
water lumbriculus toxicity test using spiked sediment (OECD Test
Guideline 225) on the PMN substances and their presumed degradation
products would help characterize the effects of the PMN substances.
Testing specifications are stated in the section 5(e) consent order for
P-12-539, P-13-107, and P-13-109 available in the docket under docket
ID number EPA-HQ-OPPT-2013-0399.
    CFR citations: 40 CFR 721.10673 (P-12-539); 40 CFR 721.10674 (P-13-
107); and 40 CFR 721.10675 (P-13-109).

PMN Number P-12-551

    Chemical name: Aromatic hydrocarbon mixture (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as feedstock for fractionation
process. Based on test data on the PMN substance and ecological
structural activity relationship (EcoSAR) analysis on analogous neutral
organics, EPA predicts toxicity to aquatic organisms may occur at
concentrations that exceed 78 ppb of the PMN substance in surface
waters. As described in the PMN, releases of the substance are not
expected to result in surface water concentrations that exceed 78 ppb.
Therefore, EPA has not determined that the proposed manufacturing,
processing, or use of the substance may present an unreasonable risk.
EPA has determined, however, that any use of the substance resulting in
surface water concentrations exceeding 78 ppb may cause significant
adverse environmental effects. Based on this information, the PMN
substance meets the concern criteria at Sec.  721.170 (b)(4)(i) and
(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a
daphnid chronic toxicity test (OPPTS Test Guideline 850.1300), a fish
early-life stage toxicity test (OPPTS Test Guideline 850.1400), and an
inherent biodegradability--Concawe test (OPPTS Test Guidelines
835.3215) would help characterize the environmental effects of the PMN
substance. EPA also recommends that the guidance document on aquatic
toxicity testing of difficult substances and mixtures (OECD Test
Guideline 23) be followed to facilitate solubility in the test media,
because of the PMN's low water solubility.
    CFR citation: 40 CFR 721.10676.

PMN Number P-12-584

    Chemical name: Alkyl phosphonate (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as an intermediate. Based on test
data on an analog substance, EPA identified concerns for eye, lung, and
mucous membrane irritation as well as kidney and developmental toxicity
to workers exposed to the PMN substance. For the use described in the
PMN, significant worker exposure is unlikely. Further, based on EcoSAR
analysis of test data on analogous phosphinate esters, EPA predicts
toxicity to aquatic organisms may occur at concentrations that exceed 1
ppb of the PMN substance in surface waters. As described in the PMN,
releases of the PMN substance are not expected to result in surface
water concentrations that exceed 1 ppb. Therefore, EPA has not
determined that the proposed manufacturing, processing, or use of the
substance may present an unreasonable risk. EPA has determined,
however, that any use of the substance other than as an intermediate,
any use of the substance without the use of impervious gloves when
there is potential dermal exposure, or any use of the substance
resulting in surface water concentrations exceeding 1 ppb may cause
serious health effects and significant adverse environmental effects.
Based on this information, the PMN substance meets the concern criteria
at Sec.  721.170 (b)(3)(ii) and (b)(4)(ii).
    Recommended testing: EPA has determined that the results of a
combined repeated dose toxicity with the reproduction/development
toxicity screening test (OPPTS Test Guideline 870.3650); an algal
toxicity test (OCSPP

Test Guideline 850.4500); an aquatic invertebrate acute toxicity test,
freshwater daphnids (OPPTS Test Guideline 850.1010); and a fish acute
toxicity test, freshwater and marine (OPPTS Test Guideline 850.1075)
would help characterize the human health and environmental effects of
the PMN substance.
    CFR citation: 40 CFR 721.10677.

PMN Number P-13-10

    Chemical name: 1,4-Cyclohexanedicarboxylic acid, 1,4-dimethyl
ester, hydrogenolysis products.
    CAS number: 1373220-73-5.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as a chemical intermediate. Based
on EcoSAR analysis of test data on analogous esters, EPA predicts
toxicity to aquatic organisms may occur at concentrations that exceed
20 ppb of the PMN substance in surface waters. As described in the PMN,
releases of the PMN substance are not expected to result in surface
water concentrations that exceed 20 ppb. Therefore, EPA has not
determined that the proposed manufacturing, processing, or use of the
substance may present an unreasonable risk. EPA has determined,
however, that any use of the substance resulting in surface water
concentrations exceeding 20 ppb may cause significant adverse
environmental effects. Based on this information, the PMN substance
meets the concern criteria at Sec.  721.170(b)(4)(ii).
    Recommended testing: EPA has determined that results of an aquatic
invertebrate acute toxicity test, freshwater daphnids (OPPTS Test
Guideline 850.1010); a fish acute toxicity test, freshwater and marine
(OPPTS Test Guideline 850.1075); and an algal toxicity test (OCSPP Test
Guideline 850.4500) would help characterize the environmental effects
of the PMN substance.
    CFR citation: 40 CFR 721.10678.

PMN Number P-13-30

    Chemical name: Carboxylic acid, substituted alkylstannylene ester,
reaction products with inorganic acid tetra alkyl ester (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as an adhesive/sealant component.
Based on test data on the PMN substance, EPA identified concerns for
thymus toxicity to workers exposed to the PMN substance. As described
in the PMN, adequate dermal protection is used and worker exposure will
be minimal and there are no consumer exposures. Therefore, EPA has not
determined that the proposed manufacturing, processing, or use of the
substance may present an unreasonable risk. EPA has determined,
however, that use of the substance in consumer products or any use of
the substance without the use of impervious gloves, when there is
potential dermal exposure, may result in significant adverse human
health effects. Based on this information, the PMN substance meets the
concern criteria at Sec.  721.170(b)(3)(i).
    Recommended testing: EPA has determined that the results of a skin
absorption: In vivo method test (OECD Test Guideline 427) would help
characterize the human health effects of the PMN substance.
    CFR citation: 40 CFR 721.10679.

PMN Numbers P-13-44, P-13-46, P-13-47, P-13-50, and P-13-51

    Chemical names: Fatty acid amides (generic).
    CAS numbers: Not available.
    Basis for action: The PMNs state that the use of the substances
will be as adhesive promoters for asphalt applications and emulsifiers
for asphalt applications. Based on the EcoSAR analysis of test data on
analogous aliphatic amines and amides, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 1 ppb of the PMN
substances respectively in surface waters for greater than 20 days per
year. This 20-day criterion is derived from partial life cycle tests
(daphnid chronic and fish early-life stage tests) that typically range
from 21 to 28 days in duration. EPA predicts toxicity to aquatic
organisms may occur if releases of the PMN substances to surface waters
exceed releases from the uses described in the PMNs. For the use
described in the PMNs, environmental releases did not exceed the
respective concentrations of concern for more than 20 days per year.
Therefore, EPA has not determined that the proposed manufacturing,
processing, or use of the substance may present an unreasonable risk.
EPA has determined, however, that any use of the substances other than
as an adhesive promoter for asphalt applications or as emulsifiers for
asphalt applications, as described in the PMNs, could result in
exposures which may cause significant adverse environmental effects.
Based on this information, the PMN substances meet the concern criteria
at Sec.  721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a fish
acute toxicity test, freshwater and marine (OPPTS Test Guideline
850.1075); an aquatic invertebrate acute toxicity test, freshwater
daphnids (OPPTS Test Guideline 850.1010); and an algal toxicity test
(OCSPP Test Guideline 850.4500) would help characterize the
environmental effects of the PMN substances. EPA also recommends that
the guidance document on aquatic toxicity testing of difficult
substances and mixtures (OECD Test Guideline 23) be followed. Testing
may be performed on any one of the PMN substances (P-13-44, P-13-46, P-
13-47, P-13-50, or P-13-51).
    CFR citation: 40 CFR 721.10680.

PMN Numbers P-13-55 and P-13-56

    Chemical names: Alkaneamide, halo-dialkylthienyl-alkoxydialkyl-,
manuf. of by-products from (generic).
    CAS numbers: Not available.
    Basis for action: The PMNs states that the generic (non-
confidential) use of the substances will be as starting material in
sulfuric acid production. Based on EcoSAR analysis of test data on
analogous haloacetamides, EPA predicts toxicity to aquatic organisms
may occur at concentrations that exceed 1 ppb of the PMN substances in
surface waters. As described in the PMN, releases of the PMN substances
are not expected to result in surface water concentrations exceeding 1
ppb. Therefore, EPA has not determined that the proposed manufacturing,
processing, or use of these substances may present an unreasonable
risk. EPA has determined, however, that any use of these substances
other than as stated in the PMN or use of the substances resulting in
releases to surface water concentrations exceeding 1 ppb may cause
significant adverse environmental effects. Based on this information,
the PMN substances meets the concern criteria at Sec.
721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of an
algal toxicity test (OCSPP Test Guideline 850.4500); an aquatic
invertebrate acute toxicity test, freshwater daphnids (OPPTS Test
Guideline 850.1010); and a fish acute toxicity test, freshwater and
marine (OPPTS Test Guideline 850.1075) would help characterize the
environmental effects of the PMN substances.
    CFR citation: 40 CFR 721.10681.

PMN Numbers P-13-63, P-13-64, P-13-65, P-13-69, P-13-70, P-13-71, P-13-
72, P-13-73, P-13-74, P-13-75, P-13-76, and P-13-77

    Chemical names: Fatty acid amide hydrochlorides (generic).
    CAS numbers: Not available.
    Basis for action: The PMNs state that the substances will be used
as

surfactants for asphalt emulsions. Based on the EcoSAR analysis of test
data on analogous aliphatic amines and amides, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 1 ppb (for P-
13-63 P-13-64, P-13-65, P-13-69, P-13-70, P-13-71 P-13-72, P-13-73, and
P-13-74) and 2 ppb (for P-13-75, P-13-76, and P-13-77) of the PMN
substances respectively in surface waters for greater than 20 days per
year. This 20-day criterion is derived from partial life cycle tests
(daphnid chronic and fish early-life stage tests) that typically range
from 21 to 28 days in duration. EPA predicts toxicity to aquatic
organisms may occur if releases of the PMN substances to surface water
exceed releases from the use described in the PMNs. For the use
described in the PMNs, environmental releases did not exceed the
respective concentrations of concern for more than 20 days per year.
Therefore, EPA has not determined that the proposed manufacturing,
processing, or use of the substance may present an unreasonable risk.
EPA has determined, however, that use of the substances other than as
surfactants for use in asphalt emulsions, as described in the PMNs,
could result in exposures which may cause significant adverse
environmental effects. Based on this information, the PMN substances
meet the concern criteria at Sec.  721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a fish
acute toxicity test, freshwater and marine (OPPTS Test Guideline
850.1075); an aquatic invertebrate acute toxicity test, freshwater
daphnids (OPPTS Test Guideline 850.1010); and an algal toxicity test
(OCSPP Test Guideline 850.4500) would help characterize the
environmental effects of the PMN substances. EPA also recommends that
the guidance document on aquatic toxicity testing of difficult
substances and mixtures (OECD Test Guideline 23) be followed. Testing
may be performed on any one of the PMN substances (P-13-63, P-13-64, P-
13-65, P-13-69, P-13-70, P-13-71, P-13-72, P-13-73, P-13-74, P-13-75,
P-13-76, or P-13-77).
    CFR citation: 40 CFR 721.10682.

PMN Number P-13-131

    Chemical name: Dialkylamino cocoalkyl alkylamide acid salt
(generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as an inhibitor for oil field
applications. Based on the EcoSAR analysis of test data on analogous
amides and aliphatic amines, EPA predicts toxicity to aquatic organisms
may occur at concentrations that exceed 1 ppb of the PMN substance in
surface waters. As described in the PMN, releases of the PMN substance
are not expected to result in surface water concentrations that exceed
1 ppb. Therefore, EPA has not determined that the proposed
manufacturing, processing, or use of the substance may present an
unreasonable risk. EPA has determined, however, that any use of the
substance resulting in surface water concentrations exceeding 1 ppb may
cause significant adverse environmental effects. Based on this
information, the PMN substance meets the concern criteria at Sec.
721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a ready
biodegradability test (OECD Test Guideline 301B), a daphnid chronic
toxicity test (OPPTS Test Guideline 850.1300), a fish early-life stage
toxicity test (OPPTS Test Guideline 850.1400), and an algal toxicity
test (OCSPP Test Guideline 850.4500) would help characterize the
environmental effects of the PMN substance.
    CFR citation: 40 CFR 721.10683.

PMN Number P-13-135

    Chemical name: Substituted benzenamine schiff base (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the use of the substance is
as an intermediate monomer for use in the manufacture of another
monomer. Based on the EcoSAR analysis of test data on analogous schiff
bases, EPA predicts toxicity to aquatic organisms may occur at
concentrations that exceed 1 ppb of the PMN substance in surface
waters. As described in the PMN, releases of the PMN substance to
surface waters are not expected. Therefore, EPA has not determined that
the proposed manufacturing, processing, or use of the substance may
present an unreasonable risk. EPA has determined, however, that any use
of the substance resulting in surface water concentrations exceeding 1
ppb may cause significant adverse environmental effects. Based on this
information, the PMN substance meets the concern criteria at Sec.
721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of an
algal toxicity test (OCSPP Test Guideline 850.4500); a daphnid chronic
toxicity test (OPPTS Test Guideline 850.1300); a fish early-stage
toxicity test (OPPTS Test Guideline 850.1400); a partition coefficient
(n-octanol/water), estimation by liquid chromatography test (OPPTS Test
Guideline 830.7570); a ready biodegradability test (OECD Test Guideline
301); and a hydrolysis as a function of pH test (OPPTS Test Guideline
835.2120) would help characterize the environmental effects of the PMN
substance.
    CFR citation: 40 CFR 721.10684.

PMN Number P-13-170

    Chemical name: Phosphoric acid, mixed esters (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as a plastic additive. Based on
test data on the PMN substance, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 1 ppb of the PMN
substance in surface waters. As described in the PMN, releases of the
PMN substance are not expected to result in surface water
concentrations that exceed 1 ppb. Therefore, EPA has not determined
that the proposed manufacturing, processing, or use of the substance
may present an unreasonable risk. EPA has determined, however, that any
use of the substance resulting in surface water concentrations
exceeding 1 ppb may cause significant adverse environmental effects.
Based on this information, the PMN substance meets the concern criteria
at Sec.  721.170(b)(4)(i).
    Recommended testing: EPA has determined that the results of a
daphnid chronic toxicity test (OPPTS Test Guideline 850.1300) and a
fish early-life stage toxicity test (OPPTS Test Guideline 850.1400)
would help characterize the environmental effects of the PMN substance.
EPA also recommends that the guidance document on aquatic toxicity
testing of difficult substances and mixtures (OECD Test Guideline 23)
be followed.
    CFR citation: 40 CFR 721.10685.

PMN Numbers P-13-180, P-13-181, P-13-182, P-13-183, P-13-184, and P-13-
185

    Chemical names: Fatty acid amides (generic).
    CAS numbers: Not available.
    Basis for action: The PMNs state that the use of the substances is
as adhesive promoters for asphalt applications and emulsifiers for
asphalt applications. Based on the EcoSAR analysis of test data on
analogous aliphatic amines and amides, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 1 ppb (for P-13-180,
P-13-182, and P-13-185); 2 ppb (for P-13-181 and P-13-183); and 4 ppb
(for P-13-184) of the PMN substances in surface waters for greater than
20 days per year. This 20-day criterion is derived from partial life
cycle tests (daphnid chronic and fish early-life stage tests) that
typically range from 21

to 28 days in duration. EPA predicts toxicity to aquatic organisms may
occur if releases of the PMN substances to surface water exceed
releases from the use described in the PMNs. For the use described in
the PMNs, environmental releases did not exceed the respective
concentrations of concern for more than 20 days per year. Therefore,
EPA has not determined that the proposed manufacturing, processing, or
use of the substance may present an unreasonable risk. EPA has
determined, however, that use of the substances other than as adhesive
promoters for asphalt applications or emulsifiers for asphalt
applications, as described in the PMNs, could result in exposures which
may cause significant adverse environmental effects. Based on this
information, the PMN substances meet the concern criteria at Sec.
721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a fish
acute toxicity test, freshwater and marine (OPPTS Test Guideline
850.1075); an aquatic invertebrate acute toxicity test, freshwater
daphnids (OPPTS Test Guideline 850.1010); and an algal toxicity test
(OCSPP Test Guideline 850.4500) would help characterize the
environmental effects of the PMN substances. EPA also recommends that
the guidance document on aquatic toxicity testing of difficult
substances and mixtures (OECD Test Guideline 23) be followed. Testing
may be performed on any one of the PMN substances (P-13-180, P-13-181,
P-13-182, P-13-183, P-13-184, or P-13-185), however, it is recommended
that it be conducted on P-13-182 as EPA predicts this substance to be
most acutely toxic to aquatic organisms.
    CFR citation: 40 CFR 721.10686.

PMN Numbers P-13-201, P-13-203, P-13-204, P-13-205, P-13-206, P-13-207,
P-13-208, and P-13-209

    Chemical names: Fatty acid amide hydrochlorides (generic).
    CAS numbers: Not available.
    Basis for action: The PMNs state that the use of the substances is
as surfactants for asphalt emulsions. Based on the EcoSAR analysis of
test data on analogous aliphatic amines, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 1 ppb (for P-
13-204, P-13-206, and P-13-207); 2 ppb (for P-13-205); 3 ppb (for P-13-
209); 5 ppb (for P-13-201); 6 ppb (for P-13-208); and 12 ppb (for P-13-
203) of the PMN substances respectively in surface waters for greater
than 20 days per year. This 20-day criterion is derived from partial
life cycle tests (daphnid chronic and fish early-life stage tests) that
typically range from 21 to 28 days in duration. EPA predicts toxicity
to aquatic organisms may occur if releases of the PMN substances to
surface waters exceed releases from the use described in the PMNs. For
the use described in the PMNs, environmental releases did not exceed
the respective surface water concentrations for more than 20 days per
year. Therefore, EPA has not determined that the proposed
manufacturing, processing, or use of the substances may present an
unreasonable risk. EPA has determined, however, that any use of the
substances other than as surfactants for asphalt emulsions could result
in exposures which may cause significant adverse environmental effects.
Based on this information, the PMN substances meet the concern criteria
at Sec.  721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a fish
acute toxicity test, freshwater and marine (OPPTS Test Guideline
850.1075); an aquatic invertebrate acute toxicity test, freshwater
daphnids (OPPTS Test Guideline 850.1010); and an algal toxicity test
(OCSPP Test Guideline 850.4500) would help characterize the
environmental effects of the PMN substances. EPA also recommends that
the guidance document on aquatic toxicity testing of difficult
substances and mixtures (OECD Test Guideline 23) be followed. Testing
may be performed on any one of the PMN substances (P-13-201, P-13-203,
P-13-204, P-13-205, P-13-206, P-13-207, P-13-208, or P-13-209).
    CFR citation: 40 CFR 721.10687.

PMN Number P-13-221

    Chemical name: Copper, chloro[tris(2-chloroethyl)
phosphite-.kappa.P]-.
    CAS number: 24484-01-3.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance will be as a manufacturing process
aid. Also, EPA identified concerns for oncogenicity, mutagenicity, and
developmental toxicity based on the alkylation potential of the PMN
substance and concern for neurotoxicity and reproductive toxicity based
on analog test data. There is also concern for immunotoxicity based on
the presence of the copper ion. These concerns are for effects to
workers from inhalation exposure to the PMN. Additionally, based on the
EcoSAR analysis of test data on analogous organic copper compounds, EPA
predicts toxicity to aquatic organisms may occur at concentrations that
exceed 6 ppb of the PMN substance in surface waters. As described in
the PMN, significant workplace exposures are not expected and releases
of the PMN substance are not expected to result in surface water
concentrations that exceed 6 ppb. Therefore, EPA has not determined
that the proposed manufacturing, processing, or use of the substance
may present an unreasonable risk. EPA has determined, however, that use
of the substance other than as described in the PMN or any use of the
substance resulting in surface water concentrations exceeding 6 ppb may
cause serious health or significant adverse environmental effects.
Based on this information, the PMN substance meets the concern criteria
at Sec.  721.170 (b)(1)(i)(C), (b)(3)(ii), and (b)(4)(ii).
    Recommended testing: EPA has determined that a carcinogenicity test
(OPPTS Test Guideline 870.4200) in rats; an aquatic invertebrate acute
toxicity test, freshwater daphnids (OPPTS Test Guideline 850.1010); a
fish acute toxicity test, freshwater and marine (OPPTS Test Guideline
850.1075); and an algal toxicity test (OCSPP Test Guideline 850.4500)
would help characterize the human health and environmental effects of
the PMN substance. EPA recommends that the guidance document on aquatic
toxicity testing of difficult substances and mixtures (OECD Test
Guideline 23) be followed.
    CFR citation: 40 CFR 721.10688.

PMN Number P-13-225

    Chemical name: Organo zinc salts (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as a stabilizer for
thermoplastics. Based on the EcoSAR analysis of test data on analogous
organic zinc compounds, EPA predicts toxicity to aquatic organisms may
occur at concentrations that exceed 3 ppb of the PMN substance in
surface waters. As described in the PMN, releases of the substance are
not expected to result in surface water concentrations that exceed 3
ppb. Therefore, EPA has not determined that the proposed manufacturing,
processing, or use of the substance may present an unreasonable risk.
EPA has determined, however, that any use of the substance resulting in
surface water concentrations exceeding 3 ppb may cause significant
adverse environmental effects. Based on this information, the PMN
substance meets the concern criteria at Sec.  721.170(b)(4)(ii).
    Recommended testing: EPA has determined that the results of a
daphnid chronic toxicity test (OPPTS Test Guideline 850.1300), a fish
early-life stage toxicity test (OPPTS Test Guideline 850.1400), and an
algal

toxicity test (OCSPP Test Guideline 850.4500) would help characterize
the environmental effects of the PMN substance.
    CFR citation: 40 CFR 721.10689.

PMN Number P-13-232

    Chemical name: Benzenedicarboxylic acid, polymer with substituted
alkanediol, dodecanedioic acid, 1,2-ethanediol, alkanedioic acid,
alkanediol,.alpha.-hydro-.omega.-hydroxypoly[oxyalkanediyl], 1,3-
isobenzofurandione, methylene diphenyl diisocyanate, 2-oxepanone, 2,2'-
oxybis[ethanol] and polymethylene polyphenylene isocyanate (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance will be as an industrial adhesive.
Based on analogous diisocyanates, EPA identified concerns for
sensitization as well as lung and mucous membrane irritation. For the
use described in the PMN, EPA does not expect significant occupational
or consumer inhalation exposure as the substance is not applied using a
method that generates a vapor, mist, or aerosol or used in a consumer
product. Therefore, EPA has not determined that the proposed
manufacturing, processing, or use of the substance may present an
unreasonable risk. EPA has determined, however, that any use of the
substance in consumer products or any use of the substance involving an
application method that generates a vapor, mist, or aerosol may cause
serious health effects. Based on this information, the PMN substance
meets the concern criteria at Sec.  721.170(b)(3)(ii).
    Recommended testing: EPA has determined that the results of a skin
sensitization test (OPPTS Test Guideline 870.2600) and a 90-day
inhalation toxicity test (OPPTS Test Guideline 870.3465) would help
characterize the human health effects of the PMN substance.
    CFR citation: 40 CFR 721.10690.

PMN Number P-13-267

    Chemical name: Fatty acid amide (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the use of the substance is
as a polymer additive. Based on the EcoSAR analysis of test data on
analogous amides, EPA predicts toxicity to aquatic organisms may occur
at concentrations that exceed 1 ppb of the PMN substance in surface
waters. As described in the PMN, releases of the PMN substance to
surface waters are not expected. Therefore, EPA has not determined that
the proposed manufacturing, processing, or use of the substance may
present an unreasonable risk. EPA has determined, however, that any use
of the substance resulting in surface water concentrations exceeding 1
ppb may cause significant adverse environmental effects. Based on this
information, the PMN substance meets the concern criteria at Sec.
721.170(b)(4)(ii).
    Recommended testing: EPA has determined that an algal toxicity test
(OCSPP Test Guideline 850.4500), a daphnid chronic toxicity test (OPPTS
Test Guideline 850.1300); a fish early-life stage toxicity test (OPPTS
Test Guideline 850.1400) and the shake flask die-away test (OPPTS Test
Guideline 835.3170) would help characterize the environmental effects
of the PMN substance. EPA recommends that the guidance document on
aquatic toxicity testing of difficult substances and mixtures (OECD
Test Guideline 23) be followed.
    CFR citation: 40 CFR 721.10691.

PMN Number P-13-288

    Chemical name: Fluorinated alkyl dianiline (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance is as a polymer precursor. EPA
identified concern for acute toxicity based on test data on the PMN
substance. Also, EPA identified concern for dermal sensitization and
oncogenicity based on benzidines; concern for neurotoxicity based on
aromatic amines; and concern for retinopathy based on dianiline
compounds. The concern is for workers exposed to the PMN substance. For
the industrial use described in the PMN, significant worker dermal or
inhalation exposure is not expected. Therefore, EPA has not determined
that the proposed manufacturing, processing, or use of the substance
may present an unreasonable risk. EPA has determined, however, that use
of the PMN substance other than as an intermediate may result in
serious health effects. Based on this information, the PMN substance
meets the concern criteria at Sec.  721.170 (b)(1)(i)(C), (b)(3)(i),
and (b)(3)(ii).
    Recommended testing: EPA has determined that the results of a rat
acute oral retinopathy screening study (protocol to be approved by EPA
to include histopathological examination of the eyes by both light and
electron microscopy) would help characterize the health effects of the
PMN substance.
    CFR citation: 40 CFR 721.10692.

PMN Number P-13-338

    Chemical name: Diphenylmethane diisocyanate polymer with alkanoic
diacid and alkanediol (generic).
    CAS number: Not available.
    Basis for action: The PMN states that the generic (non-
confidential) use of the substance will be as a polymer intermediate
for adhesive manufacture. Based on analogous diisocyanates, EPA
identified concerns for dermal and respiratory sensitization,
irritation, and lung effects. For the use described in the PMN, EPA
does not expect significant occupational or consumer inhalation
exposure as the substance is not applied using a method that generates
a vapor, mist, or aerosol or used in a consumer product. Therefore, EPA
has not determined that the proposed manufacturing, processing, or use
of the substance may present an unreasonable risk. EPA has determined,
however, that any use of the substance in consumer products or any use
of the substance involving an application method that generates a
vapor, mist, or aerosol may cause serious health effects. Based on this
information, the PMN substance meets the concern criteria at Sec.
721.170(b)(3)(ii).
    Recommended testing: EPA has determined that the results of a skin
sensitization test (OPPTS Test Guideline 870.2600) and a 90-day
inhalation toxicity test (OPPTS Test Guideline 870.3465) would help
characterize the human health effects of the PMN substance.
    CFR citation: 40 CFR 721.10693.

V. Rationale and Objectives of the Rule

A. Rationale

    During review of the PMNs submitted for the chemical substances
that are subject to these SNURs, EPA concluded that for 7 of the 53
chemical substances, regulation was warranted under TSCA section 5(e),
pending the development of information sufficient to make reasoned
evaluations of the health or environmental effects of the chemical
substances. The basis for such findings is outlined in Unit IV. Based
on these findings, TSCA section 5(e) consent orders requiring the use
of appropriate exposure controls were negotiated with the PMN
submitters. The SNUR provisions for these chemical substances are
consistent with the provisions of the TSCA section 5(e) consent orders.
These SNURs are promulgated pursuant to Sec.  14;721.160 (see Unit
VI.).
    In the other 46 cases, where the uses are not regulated under a
TSCA section 5(e) consent order, EPA determined that one or more of the
criteria of concern

established at Sec.  14;721.170 were met, as discussed in Unit IV.

B. Objectives

    EPA is issuing these SNURs for specific chemical substances which
have undergone premanufacture review because the Agency wants to
achieve the following objectives with regard to the significant new
uses designated in this rule:
     EPA will receive notice of any person's intent to
manufacture, or process a listed chemical substance for the described
significant new use before that activity begins.
     EPA will have an opportunity to review and evaluate data
submitted in a SNUN before the notice submitter begins manufacturing,
or processing a listed chemical substance for the described significant
new use.
     EPA will be able to regulate prospective manufacturers or
processors of a listed chemical substance before the described
significant new use of that chemical substance occurs, provided that
regulation is warranted pursuant to TSCA sections 5(e), 5(f), 6, or 7.
     EPA will ensure that all manufacturers and processors of
the same chemical substance that is subject to a TSCA section 5(e)
consent order are subject to similar requirements.
    Issuance of a SNUR for a chemical substance does not signify that
the chemical substance is listed on the TSCA Chemical Substance
Inventory (TSCA Inventory). Guidance on how to determine if a chemical
substance is on the TSCA Inventory is available on the Internet at
http://www.epa.gov/opptintr/existingchemicals/pubs/tscainventory/index.html.

VI. Direct Final Procedures

    EPA is issuing these SNURs as a direct final rule, as described in
Sec.  [emsp14]721.160(c)(3) and Sec.  [emsp14]721.170(d)(4). In
accordance with Sec.  [emsp14]721.160(c)(3)(ii) and Sec.
[emsp14]721.170(d)(4)(i)(B), the effective date of this rule is October
7, 2013 without further notice, unless EPA receives written adverse or
critical comments, or notice of intent to submit adverse or critical
comments before September 6, 2013.
    If EPA receives written adverse or critical comments, or notice of
intent to submit adverse or critical comments, on one or more of these
SNURs before September 6, 2013, EPA will withdraw the relevant sections
of this direct final rule before its effective date. EPA will then
issue a proposed SNUR for the chemical substance(s) on which adverse or
critical comments were received, providing a 30-day period for public
comment.
    This rule establishes SNURs for a number of chemical substances.
Any person who submits adverse or critical comments, or notice of
intent to submit adverse or critical comments, must identify the
chemical substance and the new use to which it applies. EPA will not
withdraw a SNUR for a chemical substance not identified in the comment.

VII. Applicability of the Significant New Use Designation

    To establish a significant new use, EPA must determine that the use
is not ongoing. The chemical substances subject to this rule have
undergone premanufacture review. In cases where EPA has not received a
notice of commencement (NOC) and the chemical substance has not been
added to the TSCA Inventory, no person may commence such activities
without first submitting a PMN. Therefore, for chemical substances for
which an NOC has not been submitted EPA concludes that the designated
significant new uses are not ongoing.
    When chemical substances identified in this rule are added to the
TSCA Inventory, EPA recognizes that, before the rule is effective,
other persons might engage in a use that has been identified as a
significant new use. However, TSCA section 5(e) consent orders have
been issued for 7 of the 53 chemical substances, and the PMN submitters
are prohibited by the TSCA section 5(e) consent orders from undertaking
activities which would be designated as significant new uses. The
identities of 5 of the 53 chemical substances subject to this rule have
been claimed as confidential and EPA has received no post-PMN bona fide
submissions (per Sec. Sec.  720.25 and 721.11). Based on this, the
Agency believes that it is highly unlikely that any of the significant
new uses described in the regulatory text of this rule are ongoing.
    Therefore EPA designates August 7, 2013 as the cutoff date for
determining whether the new use is ongoing. Persons who begin
commercial manufacture or processing of the chemical substances for a
significant new use identified as of that date would have to cease any
such activity upon the effective date of the final rule. To resume
their activities, these persons would have to first comply with all
applicable SNUR notification requirements and wait until the notice
review period, including any extensions, expires. If such a person met
the conditions of advance compliance under Sec.  721.45(h), the person
would be considered exempt from the requirements of the SNUR. Consult
the Federal Register document of April 24, 1990 for a more detailed
discussion of the cutoff date for ongoing uses.

VIII. Test Data and Other Information

    EPA recognizes that TSCA section 5 does not require developing any
particular test data before submission of a SNUN. The two exceptions
are:
    1. Development of test data is required where the chemical
substance subject to the SNUR is also subject to a test rule under TSCA
section 4 (see TSCA section 5(b)(1)).
    2. Development of test data may be necessary where the chemical
substance has been listed under TSCA section 5(b)(4) (see TSCA section
5(b)(2)).
    In the absence of a TSCA section 4 test rule or a TSCA section
5(b)(4) listing covering the chemical substance, persons are required
only to submit test data in their possession or control and to describe
any other data known to or reasonably ascertainable by them (see Sec.
720.50). However, upon review of PMNs and SNUNs, the Agency has the
authority to require appropriate testing. In cases where EPA issued a
TSCA section 5(e) consent order that requires or recommends certain
testing, Unit IV. lists those tests. Unit IV. also lists recommended
testing for non-section 5(e) SNURs. Descriptions of tests are provided
for informational purposes. EPA strongly encourages persons, before
performing any testing, to consult with the Agency pertaining to
protocol selection. To access the OCSPP test guidelines referenced in
this document electronically, please go to http://www.epa.gov/ocspp and
select ``Test Methods and Guidelines.'' The Organisation for Economic
Co-operation and Development (OECD) test guidelines are available from
the OECD Bookshop at http://www.oecdbookshop.org or SourceOECD at
http://www.sourceoecd.org.
    In the TSCA section 5(e) consent orders for several of the chemical
substances regulated under this rule, EPA has established production
volume limits in view of the lack of data on the potential health and
environmental risks that may be posed by the significant new uses or
increased exposure to the chemical substances. These limits cannot be
exceeded unless the PMN submitter first submits the results of toxicity
tests that would permit a reasoned evaluation of the potential risks
posed by these chemical substances. Under recent TSCA section 5(e)
consent orders, each PMN submitter is required to submit each study at
least 14 weeks (earlier TSCA section 5(e) consent orders required
submissions at least 12 weeks) before reaching the specified production
limit. Listings of

the tests specified in the TSCA section 5(e) consent orders are
included in Unit IV. The SNURs contain the same production volume
limits as the TSCA section 5(e) consent orders. Exceeding these
production limits is defined as a significant new use. Persons who
intend to exceed the production limit must notify the Agency by
submitting a SNUN at least 90 days in advance of commencement of non-
exempt commercial manufacture or processing.
    The recommended tests specified in Unit IV. may not be the only
means of addressing the potential risks of the chemical substance.
However, submitting a SNUN without any test data may increase the
likelihood that EPA will take action under TSCA section 5(e),
particularly if satisfactory test results have not been obtained from a
prior PMN or SNUN submitter. EPA recommends that potential SNUN
submitters contact EPA early enough so that they will be able to
conduct the appropriate tests.
    SNUN submitters should be aware that EPA will be better able to
evaluate SNUNs which provide detailed information on the following:
     Human exposure and environmental release that may result
from the significant new use of the chemical substances.
     Potential benefits of the chemical substances.
     Information on risks posed by the chemical substances
compared to risks posed by potential substitutes.

IX. Procedural Determinations

    By this rule, EPA is establishing certain significant new uses
which have been claimed as CBI subject to Agency confidentiality
regulations at 40 CFR part 2 and 40 CFR part 720, subpart E. Absent a
final determination or other disposition of the confidentiality claim
under 40 CFR part 2 procedures, EPA is required to keep this
information confidential. EPA promulgated a procedure to deal with the
situation where a specific significant new use is CBI, at 40 CFR
721.1725(b)(1).
    Under these procedures a manufacturer or processor may request EPA
to determine whether a proposed use would be a significant new use
under the rule. The manufacturer or processor must show that it has a
bona fide intent to manufacture or process the chemical substance and
must identify the specific use for which it intends to manufacture or
process the chemical substance. If EPA concludes that the person has
shown a bona fide intent to manufacture or process the chemical
substance, EPA will tell the person whether the use identified in the
bona fide submission would be a significant new use under the rule.
Since most of the chemical identities of the chemical substances
subject to these SNURs are also CBI, manufacturers and processors can
combine the bona fide submission under the procedure in Sec.
14;721.1725(b)(1) with that under Sec.  14;721.11 into a single step.
    If EPA determines that the use identified in the bona fide
submission would not be a significant new use, i.e., the use does not
meet the criteria specified in the rule for a significant new use, that
person can manufacture or process the chemical substance so long as the
significant new use trigger is not met. In the case of a production
volume trigger, this means that the aggregate annual production volume
does not exceed that identified in the bona fide submission to EPA.
Because of confidentiality concerns, EPA does not typically disclose
the actual production volume that constitutes the use trigger. Thus, if
the person later intends to exceed that volume, a new bona fide
submission would be necessary to determine whether that higher volume
would be a significant new use.

X. SNUN Submissions

    According to Sec.  721.1(c), persons submitting a SNUN must comply
with the same notification requirements and EPA regulatory procedures
as persons submitting a PMN, including submission of test data on
health and environmental effects as described inSec.  720.50. SNUNs
must be submitted on EPA Form No. 7710-25, generated using e-PMN
software, and submitted to the Agency in accordance with the procedures
set forth in Sec. Sec.  720.40 and 721.25. E-PMN software is available
electronically at http://www.epa.gov/opptintr/newchems.

XI. Economic Analysis

    EPA has evaluated the potential costs of establishing SNUN
requirements for potential manufacturers and processors of the chemical
substances subject to this rule. EPA's complete economic analysis is
available in the docket under docket ID number EPA-HQ-OPPT-2013-0399.

XII. Statutory and Executive Order Reviews

A. Executive Order 12866

    This rule establishes SNURs for several new chemical substances
that were the subject of PMNs, or TSCA section 5(e) consent orders. The
Office of Management and Budget (OMB) has exempted these types of
actions from review under Executive Order 12866, entitled ``Regulatory
Planning and Review'' (58 FR 51735, October 4, 1993).

B. Paperwork Reduction Act (PRA)

    According to PRA (44 U.S.C. 3501 et seq.), an agency may not
conduct or sponsor, and a person is not required to respond to a
collection of information that requires OMB approval under PRA, unless
it has been approved by OMB and displays a currently valid OMB control
number. The OMB control numbers for EPA's regulations in title 40 of
the CFR, after appearing in the Federal Register, are listed in 40 CFR
part 9, and included on the related collection instrument or form, if
applicable. EPA is amending the table in 40 CFR part 9 to list the OMB
approval number for the information collection requirements contained
in this rule. This listing of the OMB control numbers and their
subsequent codification in the CFR satisfies the display requirements
of PRA and OMB's implementing regulations at 5 CFR part 1320. This
Information Collection Request (ICR) was previously subject to public
notice and comment prior to OMB approval, and given the technical
nature of the table, EPA finds that further notice and comment to amend
it is unnecessary. As a result, EPA finds that there is ``good cause''
under section 553(b)(3)(B) of the Administrative Procedure Act (5
U.S.C. 553(b)(3)(B)) to amend this table without further notice and
comment.
    The information collection requirements related to this action have
already been approved by OMB pursuant to PRA under OMB control number
2070-0012 (EPA ICR No. 574). This action does not impose any burden
requiring additional OMB approval. If an entity were to submit a SNUN
to the Agency, the annual burden is estimated to average between 30 and
170 hours per response. This burden estimate includes the time needed
to review instructions, search existing data sources, gather and
maintain the data needed, and complete, review, and submit the required
SNUN.
    Send any comments about the accuracy of the burden estimate, and
any suggested methods for minimizing respondent burden, including
through the use of automated collection techniques, to the Director,
Collection Strategies Division, Office of Environmental Information
(2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460-0001. Please remember to include the OMB control
number in any correspondence, but do not submit any completed forms to
this address.

C. Regulatory Flexibility Act (RFA)

    On February 18, 2012, EPA certified pursuant to RFA section 605(b)
(5 U.S.C. 601 et seq.), that promulgation of a SNUR does not have a
significant economic impact on a substantial number of small entities
where the following are true:
    1. A significant number of SNUNs would not be submitted by small
entities in response to the SNUR.
    2. The SNUR submitted by any small entity would not cost
significantly more than $8,300.
A copy of that certification is available in the docket for this rule.
    This rule is within the scope of the February 18, 2012
certification. Based on the Economic Analysis discussed in Unit XI. and
EPA's experience promulgating SNURs (discussed in the certification),
EPA believes that the following are true:
     A significant number of SNUNs would not be submitted by
small entities in response to the SNUR.
     Submission of the SNUN would not cost any small entity
significantly more than $8,300.
Therefore, the promulgation of the SNUR would not have a significant
economic impact on a substantial number of small entities.

D. Unfunded Mandates Reform Act (UMRA)

    Based on EPA's experience with proposing and finalizing SNURs,
State, local, and Tribal governments have not been impacted by these
rulemakings, and EPA does not have any reasons to believe that any
State, local, or Tribal government will be impacted by this rule. As
such, EPA has determined that this rule does not impose any enforceable
duty, contain any unfunded mandate, or otherwise have any effect on
small governments subject to the requirements of UMRA sections 202,
203, 204, or 205 (2 U.S.C. 1501 et seq.).

E. Executive Order 13132

    This action will not have a substantial direct effect on States, on
the relationship between the national government and the States, or on
the distribution of power and responsibilities among the various levels
of government, as specified in Executive Order 13132, entitled
``Federalism'' (64 FR 43255, August 10, 1999).

F. Executive Order 13175

    This rule does not have Tribal implications because it is not
expected to have substantial direct effects on Indian Tribes. This rule
does not significantly nor uniquely affect the communities of Indian
Tribal governments, nor does it involve or impose any requirements that
affect Indian Tribes. Accordingly, the requirements of Executive Order
13175, entitled ``Consultation and Coordination with Indian Tribal
Governments'' (65 FR 67249, November 9, 2000), do not apply to this
rule.

G. Executive Order 13045

    This action is not subject to Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997), because this is not an
economically significant regulatory action as defined by Executive
Order 12866, and this action does not address environmental health or
safety risks disproportionately affecting children.

H. Executive Order 13211

    This action is not subject to Executive Order 13211, entitled
``Actions Concerning Regulations That Significantly Affect Energy
Supply, Distribution, or Use'' (66 FR 28355, May 22, 2001), because
this action is not expected to affect energy supply, distribution, or
use and because this action is not a significant regulatory action
under Executive Order 12866.

I. National Technology Transfer and Advancement Act (NTTAA)

    In addition, since this action does not involve any technical
standards, NTTAA section 12(d) (15 U.S.C. 272 note), does not apply to
this action.

J. Executive Order 12898

    This action does not entail special considerations of environmental
justice related issues as delineated by Executive Order 12898, entitled
``Federal Actions to Address Environmental Justice in Minority
Populations and Low-Income Populations'' (59 FR 7629, February 16,
1994).

XIII. Congressional Review Act

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).

List of Subjects

40 CFR Part 9

    Environmental protection, Reporting and recordkeeping requirements.

40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances,
Reporting and recordkeeping requirements.

    Dated: July 30, 2013.
Maria J. Doa,
Director, Chemical Control Division, Office of Pollution Prevention and
Toxics.
    Therefore, 40 CFR parts 9 and 721 are amended as follows:

PART 9--[AMENDED]

0
1. The authority citation for part 9 continues to read as follows:

    Authority: 7 U.S.C. 135 et seq., 136-136y; 15 U.S.C. 2001, 2003,
2005, 2006, 2601-2671; 21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33
U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 1321, 1326, 1330,
1342, 1344, 1345(d) and (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR,
1971-1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f, 300g,
300g-1, 300g-2, 300g-3, 300g-4, 300g-5, 300g-6, 300j-1, 300j-2,
300j-3, 300j-4, 300j-9, 1857 et seq., 6901-6992k, 7401-7671q, 7542,
9601-9657, 11023, 11048.

0
2. In Sec.  9.1, add the following sections in numerical order under
the undesignated center heading ``Significant New Uses of Chemical
Substances'' to read as follows:

Sec.  [emsp14]9.1  OMB approvals under the Paperwork Reduction Act.

* * * * *

------------------------------------------------------------------------
                                                           OMB  control
                     40 CFR citation                            No.
------------------------------------------------------------------------

------------------------------------------------------------------------
                                * * * * *
               Significant New Uses of Chemical Substances
------------------------------------------------------------------------

------------------------------------------------------------------------
                                * * * * *
721.10671...............................................       2070-0012
721.10672...............................................       2070-0012
721.10673...............................................       2070-0012
721.10674...............................................       2070-0012
721.10675...............................................       2070-0012
721.10676...............................................       2070-0012
721.10677...............................................       2070-0012
721.10678...............................................       2070-0012
721.10679...............................................       2070-0012
721.10680...............................................       2070-0012
721.10681...............................................       2070-0012
721.10682...............................................       2070-0012
721.10683...............................................       2070-0012
721.10684...............................................       2070-0012
721.10685...............................................       2070-0012
721.10686...............................................       2070-0012
721.10687...............................................       2070-0012
721.10688...............................................       2070-0012
721.10689...............................................       2070-0012
721.10690...............................................       2070-0012
721.10691...............................................       2070-0012
721.10692...............................................       2070-0012
721.10693...............................................       2070-0012

                                * * * * *
------------------------------------------------------------------------

* * * * *

PART 721--[AMENDED]

0
3. The authority citation for part 721 continues to read as follows:

    Authority: 15 U.S.C. 2604, 2607, and 2625(c).

0
4. Add Sec.  [emsp14]721.10671 to subpart E to read as follows:

Sec.  [emsp14]721.10671  Multi-walled carbon nanotubes (generic).

    (a) Chemical substances and significant new uses subject to
reporting. (1) The chemical substances identified generically as multi-
walled carbon nanotubes (PMNs P-09-198 and P-09-199) are subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this rule do not
apply to quantities of the PMN substances after they have been
completely reacted (cured); embedded or incorporated into a polymer
matrix that itself has been reacted (cured); or embedded in a permanent
solid polymer form that is not intended to undergo further processing,
except mechanical processing.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.
721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), (a)(4) (National
Institute of Occupational Safety and Health (NIOSH)-certified air-
purifying, tight-fitting full-face respirator equipped with N100
filters), (a)(6)(i), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec.  721.63 (a)(1) and
(a)(4), engineering control measures (e.g., enclosure or confinement of
the operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80 (f), (k), and (q).
    (iii) Release to water. Requirements as specified in Sec.  721.90
(b)(1) and (c)(1).
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (d), (e), (i), and (k) are applicable to
manufacturers and processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of
this section.

0
5. Add Sec.  [emsp14]721.10672 to subpart E to read as follows:

Sec.  [emsp14]721.10672  Sodium olefin sulfonate derivative (generic).

    (a) Chemical substances and significant new uses subject to
reporting. (1) The chemical substances identified generically as sodium
olefin sulfonate derivative (PMNs P-09-447 and P-09-448) are subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this rule do not
apply to quantities of the chemical substances after they have been
completely reacted (cured) or partitioned into oil or petroleum streams
following use as specific enhanced oil recovery applications that have
been claimed confidential.
    (2) The significant new uses are:
    (i) Hazard communication program. Requirements as specified in
Sec.  721.72 (a), (b), (c). (d), (e) (concentration set at 1.0
percent), (f), (g)(3)(i), (g)(3)(ii), (g)(4)(i), and (g)(5).
    (ii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(k).
    (iii) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=10).
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (f), (g), (h), (i), and (k) are applicable to
manufacturers and processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(1) of
this section.

0
6. Add Sec.  721.10673 to subpart E to read as follows:

Sec.  [emsp14]721.10673  Alkanes, C21-34--branched and linear, chloro.

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as alkanes, C21-34--
branched and linear, chloro (PMN P-12-539; CAS No. 1417900-96-9) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is manufacture of
the PMN substance with greater than 1 weight percent (``wt%'') of
chlorinated (``Cl'') paraffins with an alkyl chain <= 20 and Sec.
721.80(r) (Testing phase 1 is reached at 1,200,000 kg for the aggregate
of the PMN substances P-12-539, P-13-107, and P-13-109. Testing
includes analysis for chain length and percent chlorination (for
example by gas chromatography-mass spectrometry or high performance
liquid chromatography-mass spectrometry). Present EPA with a
certificate of analysis and all raw data for congener analysis on P-12-
539, P-13-107, and P-13-109. Testing phase 2a is reached at 14,100,000
kg for the aggregate of the PMN substances P-12-539, P-13-107, and P-
13-109. Testing includes a modified semi-continuous activated sludge
(SCAS) test or modified SCAS test for insoluble and volatile chemicals
or Zahn Wellens test with analytical procedures capable of measuring
individual congeners and degradation products over time on three
chlorinated linear C21 paraffin fractions to represent each of the 40%,
55%, and > 70% chlorine by weight, three chlorinated C26 linear
paraffin fractions to represent each of the 40%, 55%, and > 70%
chlorine by weight, three chlorinated linear paraffin fractions, whose
chain length represents the central tendency of the congener
distribution of the very long chain chlorinated paraffins (vLCCP)
product as identified in testing phase 1, to represent each of the 40%,
55%, and > 70% chlorine by weight. Testing phase 2b is reached at
59,100,000 kg for the aggregate of the PMN substances P-12-539, P-13-
107, and P-13-109. Testing includes aerobic and anaerobic
transformation in soil test with analytical procedures capable of
measuring individual congeners and degradation products over time and
bioaccumulation in sediment-dwelling benthic oligochaetes on three
chlorinated linear C21 paraffin fractions to represent each of the 40%,
55%, and > 70% chlorine by weight, three chlorinated C26 linear
paraffin fractions to represent each of the 40%, 55%, and > 70%
chlorine by weight, three chlorinated linear paraffin fractions, whose
chain length represents the central tendency of the congener
distribution of the vLCCP product as identified in testing phase 1, to
represent each of the 40%, 55%, and

 > 70% chlorine by weight. Testing phase 3 is reached at 78,400,000 kg
for the aggregate of the PMN substances P-12-539, P-13-107, and P-13-
109. If the degradation half-life of the test substance is 28 days or
shorter from testing phase 2a the sediment-water chironomid life-cycle
toxicity test using spiked water or spiked sediment is an acceptable
test, otherwise sediment-water lumbriculus toxicity test using spiked
sediment is an acceptable test for any of the parent substances that
are absorbed by the benthic oligochaetes in the bioaccumulation in
sediment-dwelling benthic oligochaetes test. In the bioaccumulation in
sediment-dwelling benthic oligochaetes test, use as test material any
of the degradation products in testing phases 2a or 2b that are
identified to potentially present an unreasonable risk or to further
degrade to generate a substance of potential concern. Testing phase 4
is reached at 86,100,000 kg for the aggregate of the PMN substances P-
12-539, P-13-107, and P-13-109. If the degradation half-life of the
test substance is 28 days or shorter from testing phase 3 the sediment-
water chironomid life-cycle toxicity test using spiked water or spiked
sediment is an acceptable test, otherwise the sediment-water
lumbriculus toxicity test using spiked sediment is an acceptable test.
Use degradation substances in testing phase 3 that are absorbed by the
benthic oligochaetes as the test material.)
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
7. Add Sec.  [emsp14]721.10674 to subpart E to read as follows:

Sec.  [emsp14]721.10674  Alkanes, C22-30--branched and linear, chloro.

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as alkanes, C22-30--
branched and linear, chloro (PMN P-13-107; CAS No. 1401947-24-0) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is manufacture of
the PMN substance with greater than 1 weight percent (``wt%'') of
chlorinated (``Cl'') paraffins with an alkyl chain <= 20 and Sec.
721.80(r) (Testing phase 1 is reached at 1,200,000 kg for the aggregate
of the PMN substances P-12-539, P-13-107, and P-13-109. Testing
includes analysis for chain length and percent chlorination (for
example by gas chromatography-mass spectrometry or high performance
liquid chromatography-mass spectrometry). Present EPA with a
certificate of analysis and all raw data for congener analysis on P-12-
539, P-13-107, and P-13-109. Testing phase 2a is reached at 14,100,000
kg for the aggregate of the PMN substances P-12-539, P-13-107, and P-
13-109. Testing includes a modified semi-continuous activated sludge
(SCAS) test or modified SCAS test for insoluble and volatile chemicals
or Zahn Wellens test with analytical procedures capable of measuring
individual congeners and degradation products over time on three
chlorinated linear C21 paraffin fractions to represent each of the 40%,
55%, and > 70% chlorine by weight, three chlorinated C26 linear
paraffin fractions to represent each of the 40%, 55%, and > 70%
chlorine by weight, three chlorinated linear paraffin fractions, whose
chain length represents the central tendency of the congener
distribution of the very long chain chlorinated paraffins (vLCCP)
product as identified in testing phase 1, to represent each of the 40%,
55%, and > 70% chlorine by weight. Testing phase 2b is reached at
59,100,000 kg for the aggregate of the PMN substances P-12-539, P-13-
107, and P-13-109. Testing includes aerobic and anaerobic
transformation in soil test with analytical procedures capable of
measuring individual congeners and degradation products over time and
bioaccumulation in sediment-dwelling benthic oligochaetes on three
chlorinated linear C21 paraffin fractions to represent each of the 40%,
55%, and > 70% chlorine by weight, three chlorinated C26 linear
paraffin fractions to represent each of the 40%, 55%, and > 70%
chlorine by weight, three chlorinated linear paraffin fractions, whose
chain length represents the central tendency of the congener
distribution of the vLCCP product as identified in testing phase 1, to
represent each of the 40%, 55%, and > 70% chlorine by weight. Testing
phase 3 is reached at 78,400,000 kg for the aggregate of the PMN
substances P-12-539, P-13-107, and P-13-109. If the degradation half-
life of the test substance is 28 days or shorter from testing phase 2a
the sediment-water chironomid life-cycle toxicity test using spiked
water or spiked sediment is an acceptable test, otherwise sediment-
water lumbriculus toxicity test using spiked sediment is an acceptable
test for any of the parent substances that are absorbed by the benthic
oligochaetes in the bioaccumulation in sediment-dwelling benthic
oligochaetes test. In the bioaccumulation in sediment-dwelling benthic
oligochaetes test, use as test material any of the degradation products
in testing phases 2a or 2b that are identified to potentially present
an unreasonable risk or to further degrade to generate a substance of
potential concern. Testing phase 4 is reached at 86,100,000 kg for the
aggregate of the PMN substances P-12-539, P-13-107, and P-13-109. If
the degradation half-life of the test substance is 28 days or shorter
from testing phase 3 the sediment-water chironomid life-cycle toxicity
test using spiked water or spiked sediment is an acceptable test,
otherwise the sediment-water lumbriculus toxicity test using spiked
sediment is an acceptable test. Use degradation substances in testing
phase 3 that are absorbed by the benthic oligochaetes as the test
material.)
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
8. Add Sec.  [emsp14]721.10675 to subpart E to read as follows:

Sec.  [emsp14]721.10675  Alkanes, C24-28, chloro.

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as alkanes, C24-28,
chloro (PMN P-13-109; CAS No. 1402738-52-6) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is manufacture of
the PMN substance with greater than 1 weight percent (``wt%'') of
chlorinated (``Cl'') paraffins with an alkyl chain <= 20 and Sec.
721.80(r) (Testing phase 1 is reached at 1,200,000 kg for the aggregate
of the

PMN substances P-12-539, P-13-107, and P-13-109. Testing includes
analysis for chain length and percent chlorination (for example by gas
chromatography-mass spectrometry or high performance liquid
chromatography-mass spectrometry). Present EPA with a certificate of
analysis and all raw data for congener analysis on P-12-539, P-13-107,
and P-13-109. Testing phase 2a is reached at 14,100,000 kg for the
aggregate of the PMN substances P-12-539, P-13-107, and P-13-109.
Testing includes a modified semi-continuous activated sludge (SCAS)
test or modified SCAS test for insoluble and volatile chemicals or Zahn
Wellens test with analytical procedures capable of measuring individual
congeners and degradation products over time on three chlorinated
linear C21 paraffin fractions to represent each of the 40%, 55%, and >
70% chlorine by weight, three chlorinated C26 linear paraffin fractions
to represent each of the 40%, 55%, and > 70% chlorine by weight, three
chlorinated linear paraffin fractions, whose chain length represents
the central tendency of the congener distribution of the very long
chain chlorinated paraffins (vLCCP) product as identified in testing
phase 1, to represent each of the 40%, 55%, and > 70% chlorine by
weight. Testing phase 2b is reached at 59,100,000 kg for the aggregate
of the PMN substances P-12-539, P-13-107, and P-13-109. Testing
includes aerobic and anaerobic transformation in soil test with
analytical procedures capable of measuring individual congeners and
degradation products over time and bioaccumulation in sediment-dwelling
benthic oligochaetes on three chlorinated linear C21 paraffin fractions
to represent each of the 40%, 55%, and > 70% chlorine by weight, three
chlorinated C26 linear paraffin fractions to represent each of the 40%,
55%, and > 70% chlorine by weight, three chlorinated linear paraffin
fractions, whose chain length represents the central tendency of the
congener distribution of the vLCCP product as identified in testing
phase 1, to represent each of the 40%, 55%, and > 70% chlorine by
weight. Testing phase 3 is reached at 78,400,000 kg for the aggregate
of the PMN substances P-12-539, P-13-107, and P-13-109. If the
degradation half-life of the test substance is 28 days or shorter from
testing phase 2a the sediment-water chironomid life-cycle toxicity test
using spiked water or spiked sediment is an acceptable test, otherwise
sediment-water lumbriculus toxicity test using spiked sediment is an
acceptable test for any of the parent substances that are absorbed by
the benthic oligochaetes in the bioaccumulation in sediment-dwelling
benthic oligochaetes test. In the bioaccumulation in sediment-dwelling
benthic oligochaetes test, use as test material any of the degradation
products in testing phases 2a or 2b that are identified to potentially
present an unreasonable risk or to further degrade to generate a
substance of potential concern. Testing phase 4 is reached at
86,100,000 kg for the aggregate of the PMN substances P-12-539, P-13-
107, and P-13-109. If the degradation half-life of the test substance
is 28 days or shorter from testing phase 3 the sediment-water
chironomid life-cycle toxicity test using spiked water or spiked
sediment is an acceptable test, otherwise the sediment-water
lumbriculus toxicity test using spiked sediment is an acceptable test.
Use degradation substances in testing phase 3 that are absorbed by the
benthic oligochaetes as the test material.)
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
9. Add Sec.  [emsp14]721.10676 to subpart E to read as follows:

Sec.  [emsp14]721.10676  Aromatic hydrocarbon mixture (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
aromatic hydrocarbon mixture (PMN P-12-551) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=78).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
10. Add Sec.  [emsp14]721.10677 to subpart E to read as follows:

Sec.  [emsp14]721.10677  Alkyl phosphonate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as alkyl
phosphonate (PMN P-12-584) is subject to reporting under this section
for the significant new uses described in paragraph (a)(2) of this
section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(g).
    (ii) Protection in the workplace. Requirements as specified in
Sec.  721.63 (a)(1), (a)(2)(i), and (a)(3). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63 (a)(1) and (a)(4), engineering control measures (e.g., enclosure
or confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
    (iii) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (d), (e), (i), and (k) are applicable to
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
11. Add Sec.  [emsp14]721.10678 to subpart E to read as follows:

Sec.  [emsp14]721.10678  1,4-Cyclohexanedicarboxylic acid, 1,4-dimethyl
ester, hydrogenolysis products.

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as 1,4-
cyclohexanedicarboxylic acid, 1,4-dimethyl ester, hydrogenolysis
products (PMN P-13-10; CAS No. 1373220-73-5) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=20).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part

apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
12. Add Sec.  [emsp14]721.10679 to subpart E to read as follows:

Sec.  [emsp14]721.10679  Carboxylic acid, substituted alkylstannylene
ester, reaction products with inorganic acid tetra alkyl ester
(generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
carboxylic acid, substituted alkylstannylene ester, reaction products
with inorganic acid tetra alkyl ester (PMN P-13-30) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(o).
    (ii) Protection in the workplace. Requirements as specified in
Sec.  721.63 (a)(1), (a)(2)(i), (a)(3), (b) (concentration set at
1.0%), and (c). When determining which persons are reasonably likely to
be exposed as required for Sec.  721.63 (a)(1) and (a)(4), engineering
control measures (e.g., enclosure or confinement of the operation,
general and local ventilation) or administrative control measures
(e.g., workplace policies and procedures) shall be considered and
implemented to prevent exposure, where feasible.
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (d), and (e) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
13. Add Sec.  [emsp14]721.10680 to subpart E to read as follows:

Sec.  [emsp14]721.10680  Fatty acid amides (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as fatty
acid amides (PMNs P-13-44, P-13-46, P-13-47, P-13-50, and P-13-51) are
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is any use other
than as adhesion promoters for asphalt applications or emulsifiers for
asphalt applications.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
14. Add Sec.  [emsp14]721.10681 to subpart E to read as follows:

Sec.  [emsp14]721.10681  Alkaneamide, halo-dialkylthienyl-
alkoxydialkyl-, manuf. of by-products from (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as
alkaneamide, halo-dialkylthienyl-alkoxydialkyl-, manuf. of by-products
from (PMNs P-13-55 and PMN P-13-56) are subject to reporting under this
section for the significant new uses described in paragraph (a)(2) of
this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(j).
    (ii) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (i) and (k) are applicable to manufacturers and
processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(i) of
this section.

0
15. Add Sec.  [emsp14]721.10682 to subpart E to read as follows:

Sec.  [emsp14]721.10682  Fatty acid amide hydrochlorides (generic).

    (a) Chemical substances and significant new uses subject to
reporting. (1) The chemical substances identified generically as fatty
acid amide hydrochlorides (PMNs P-13-63, P-13-64, P-13-65, P-13-69, P-
13-70, P-13-71, P-13-72, P-13-73, P-13-74, P-13-75, P-13-76, and P-13-
77) are subject to reporting under this section for the significant new
uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is any use other
than as surfactants for use in asphalt emulsions.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
16. Add Sec.  [emsp14]721.10683 to subpart E to read as follows:

Sec.  [emsp14]721.10683  Dialkylamino cocoalkyl alkylamide acid salt
(generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
dialkylamino cocoalkyl alkylamide acid salt (PMN P-13-131) is subject
to reporting under this section for the significant new uses described
in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
17. Add Sec.  [emsp14]721.10684 to subpart E to read as follows:

Sec.  [emsp14]721.10684  Substituted benzenamine schiff base (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
substituted benzenamine schiff base (PMN P-13-135) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
18. Add Sec.  [emsp14]721.10685 to subpart E to read as follows:

Sec.  [emsp14]721.10685  Phosphoric acid, mixed esters (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
phosphoric acid, mixed esters (PMN P-13-170) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
19. Add Sec.  [emsp14]721.10686 to subpart E to read as follows:

Sec.  [emsp14]721.10686  Fatty acid amides (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as fatty
acid amides (PMNs P-13-180, P-13-181, P-13-182, P-13-183, P-13-184, and
P-13-185) are subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is any use other
than as adhesion promoters for asphalt applications or emulsifiers for
asphalt applications.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
20. Add Sec.  [emsp14]721.10687 to subpart E to read as follows:

Sec.  [emsp14]721.10687  Fatty acid amide hydrochlorides (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substances identified generically as fatty
acid amide hydrochlorides (PMNs P-13-201, P-13-203, P-13-204, P-13-205,
P-13-206, P-13-207, P-13-208, and P-13-209) are subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80. A significant new use is any use other
than as surfactants for asphalt emulsions.
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of these substances.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
21. Add Sec.  [emsp14]721.10688 to subpart E to read as follows:

Sec.  [emsp14]721.10688  Copper, chloro[tris(2-chloroethyl)
phosphite-.kappa.P]-.

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified as copper,
chloro[tris(2-chloroethyl) phosphite-.kappa.P]- (PMN P-13-221; CAS No.
24484-01-3) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(j).
    (ii) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=6).
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), (i), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section.
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(i) of
this section.

0
22. Add Sec.  [emsp14]721.10689 to subpart E to read as follows:

Sec.  [emsp14]721.10689  Organo zinc salts (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as organo
zinc salts (PMN P-13-225) is subject to reporting under this section
for the significant new uses described in paragraph (a)(2) of this
section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=3).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
23. Add Sec.  [emsp14]721.10690 to subpart E to read as follows:

Sec.  [emsp14]721.10690  Benzenedicarboxylic acid, polymer with
substituted alkanediol, dodecanedioic acid, 1,2-ethanediol, alkanedioic
acid, alkanediol,.alpha.-hydro-.omega.-hydroxypoly[oxyalkanediyl], 1,3-
isobenzofurandione, methylene diphenyl diisocyanate, 2-oxepanone, 2,2'-
oxybis[ethanol] and polymethylene polyphenylene isocyanate (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
benzenedicarboxylic acid, polymer with substituted alkanediol,
dodecanedioic acid, 1,2-ethanediol, alkanedioic acid,
alkanediol,.alpha.-hydro-.omega.-hydroxypoly[oxyalkanediyl], 1,3-
isobenzofurandione, methylene diphenyl diisocyanate, 2-oxepanone, 2,2'-
oxybis[ethanol] and polymethylene polyphenylene isocyanate (PMN P-13-
232) is subject to reporting under this section for the significant new
uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80 (o) and (y)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
24. Add Sec.  [emsp14]721.10691 to subpart E to read as follows:

Sec.  [emsp14]721.10691  Fatty acid amide (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as fatty
acid amide (PMN P-13-267) is subject to reporting under this section
for the significant new uses described in paragraph (a)(2) of this
section.
    (2) The significant new uses are:
    (i) Release to water. Requirements as specified in Sec.  721.90
(a)(4), (b)(4), and (c)(4) (N=1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (k) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
25. Add Sec.  [emsp14]721.10692 to subpart E to read as follows:

Sec.  [emsp14]721.10692  Fluorinated alkyl dianiline (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
fluorinated alkyl dianiline (PMN P-13-288) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80(g).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

0
26. Add Sec.  [emsp14]721.10693 to subpart E to read as follows:

Sec.  [emsp14]721.10693  Diphenylmethane diisocyanate polymer with
alkanoic diacid and alkanediol (generic).

    (a) Chemical substance and significant new uses subject to
reporting. (1) The chemical substance identified generically as
diphenylmethane diisocyanate polymer with alkanoic diacid and
alkanediol (PMN P-13-338) is subject to reporting under this section
for the significant new uses described in paragraph (a)(2) of this
section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements
as specified in Sec.  721.80 (o) and (y)(1).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part
apply to this section except as modified by this paragraph.
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125 (a), (b), (c), and (i) are applicable to manufacturers and
processors of this substance.
    (2) Limitations or revocation of certain notification requirements.
The provisions of Sec.  721.185 apply to this section.

[FR Doc. 2013-18982 Filed 8-6-13; 8:45 am]
BILLING CODE 6560-50-P